[go: up one dir, main page]

DK0625900T3 - Sammensætninger og fremgangsmåder til langvarig frigivelse af lægemidler - Google Patents

Sammensætninger og fremgangsmåder til langvarig frigivelse af lægemidler

Info

Publication number
DK0625900T3
DK0625900T3 DK93905844.2T DK93905844T DK0625900T3 DK 0625900 T3 DK0625900 T3 DK 0625900T3 DK 93905844 T DK93905844 T DK 93905844T DK 0625900 T3 DK0625900 T3 DK 0625900T3
Authority
DK
Denmark
Prior art keywords
compositions
drugs
methods
prolonged release
somatotropin
Prior art date
Application number
DK93905844.2T
Other languages
Danish (da)
English (en)
Inventor
Siva N Raman
Matthew W Gray
Rodger L Smith
Original Assignee
Mallinckrodt Veterinary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc
Application granted granted Critical
Publication of DK0625900T3 publication Critical patent/DK0625900T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93905844.2T 1992-02-10 1993-02-09 Sammensætninger og fremgangsmåder til langvarig frigivelse af lægemidler DK0625900T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/833,197 US5328697A (en) 1992-02-10 1992-02-10 Compositions and processes for the sustained release of drugs

Publications (1)

Publication Number Publication Date
DK0625900T3 true DK0625900T3 (da) 1997-06-02

Family

ID=25263729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93905844.2T DK0625900T3 (da) 1992-02-10 1993-02-09 Sammensætninger og fremgangsmåder til langvarig frigivelse af lægemidler

Country Status (13)

Country Link
US (1) US5328697A (fr)
EP (1) EP0625900B1 (fr)
JP (1) JPH08502020A (fr)
CN (1) CN1071113C (fr)
AT (1) ATE145552T1 (fr)
AU (1) AU669884B2 (fr)
CA (1) CA2129754A1 (fr)
DE (1) DE69306243T2 (fr)
DK (1) DK0625900T3 (fr)
ES (1) ES2095045T3 (fr)
NZ (1) NZ249658A (fr)
TW (1) TW272133B (fr)
WO (1) WO1993015725A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (ko) * 1996-01-10 1999-07-15 성재갑 지속성 동물 성장 호르몬 제형 및 이의 제조 방법
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
GB9910975D0 (en) * 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
AU781718B2 (en) * 1999-11-02 2005-06-09 Depomed, Inc. Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
GB0116074D0 (en) * 2001-06-29 2001-08-22 Univ Strathclyde Nanoparticle structures
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
FR3007651A1 (fr) * 2013-06-27 2015-01-02 Assist Publ Hopitaux De Paris Composition pharmaceutique sous forme de granules pour le traitement de desordres metaboliques chez l'enfant
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3220925A (en) * 1962-11-15 1965-11-30 Upjohn Co Tetracycline-novobiocin compositions and method of use
BE640616A (fr) * 1962-12-19
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung

Also Published As

Publication number Publication date
ES2095045T3 (es) 1997-02-01
WO1993015725A1 (fr) 1993-08-19
NZ249658A (en) 1996-05-28
JPH08502020A (ja) 1996-03-05
DE69306243T2 (de) 1997-03-20
ATE145552T1 (de) 1996-12-15
CA2129754A1 (fr) 1993-08-11
CN1071113C (zh) 2001-09-19
TW272133B (fr) 1996-03-11
EP0625900B1 (fr) 1996-11-27
DE69306243D1 (de) 1997-01-09
CN1075253A (zh) 1993-08-18
US5328697A (en) 1994-07-12
AU669884B2 (en) 1996-06-27
AU3661093A (en) 1993-09-03
EP0625900A1 (fr) 1994-11-30

Similar Documents

Publication Publication Date Title
DK0625900T3 (da) Sammensætninger og fremgangsmåder til langvarig frigivelse af lægemidler
DK0758248T3 (da) Formuleringer til faktor IX
MY113488A (en) Compounds with growth hormone releasing properties
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
IT8921118A0 (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
DK0747116T3 (da) Fremgangsmåde til fremstilling af mikrokapselsammensætninger
DE68916996D1 (de) Anwuchsverhindernde Überzugszusammensetzung.
DE58905460D1 (de) Verfahren zur Herstellung und Applikation von unter Feuchtigkeitseinwirkung nachvernetzenden Schmelzklebermassen.
DE3763149D1 (de) Spruehkopf zur pulverbeschichtung.
NO872260D0 (no) Fremgangsmaate for sliping av silisiumkarbid til pulver.
TR22328A (tr) Laklarin,mumlarin ve sivama maddelerinin pihtilastirilmasina mahsus madde
FI913592A7 (fi) Valmistustapoja verihiutaleiden aktivaation polypeptidi-inhibiittoreid en tuottamiseksi sekä menetelmiä, yhdistelmiä ja koostumuksia, joissa niitä käytetään
IS5646A (is) Aðferð til að breyta prótínbyggingu fóðurtaflna, fóðurkúlna eða annarra fóðurköggla sem fengið hafalokalögun til að ná fram stöðugleika í lögun, og fóðurmassa í samræmi við það sem aðferðin segir til um
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
PL337279A1 (en) Pharmaceutical with controlled releose containing inhibitor ace as an active substance
DK258789D0 (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
DK0684816T3 (da) 5-HT2-receptorantagonister til behandling af venöse tilstande
DK0783521T3 (da) Polypeptidforbindelser indeholdende D-2-alkyltryptophan, hvilke er i stand til at fremme frigivelsen af væksthormon
DE68907432D1 (de) Beschichtete granulierte duengemittelzusammensetzung und ihre herstellung.
DK574889D0 (da) Pulverbelaegningsanlaeg til lange genstande
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
ATE60788T1 (de) Derivat von p-aminophenol mit mucrosekretolytischer fluessiger und antipyretischer wirksamkeit, dessen verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
MX9400072A (es) Agentes antiinflamatorios derivados de difluoropentapeptido.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
NO890803D0 (no) Fremgangsmaate for fremstilling av trisubstituerte aminer.